About Immunology


Recent advances in the understanding of immune pathways guide our development of treatments for autoimmune diseases. These insights yield new targets and new ways to select patients for treatment—vital capabilities to address diseases with high unmet need.   

Roche Immunology focuses on expanding treatment opportunities and improving patient quality of life in rheumatoid arthritis, juvenile arthritis, giant cell arteritis, systemic sclerosis and inflammatory bowel disease.